CERo Therapeutics Holdings, Inc. (CERO)

NASDAQ: CERO · IEX Real-Time Price · USD

0.200

-0.043 (-17.66%)

At close: Jul 19, 2024, 4:00 PM

0.194

-0.006 (-3.00%)

Pre-market: Jul 22, 2024, 9:17 AM EDT

CERO Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	4	69	236	228
Market Cap Growth	-49.35%	-70.89%	3.64%	-
Enterprise Value	2	70	232	212
PE Ratio	-	-9.43	-19.95	-21.42
PB Ratio	-9.20	-1.63	-6.77	-9.72
P/FCF Ratio	-	-11.87	-19.03	-21.27
P/OCF Ratio	-	-11.87	-20.16	-22.56
EV/EBITDA Ratio	-	-11.35	-21.59	-21.44
EV/EBIT Ratio	-	-9.61	-19.63	-19.96
EV/FCF Ratio	-	-12.10	-18.72	-19.81
Debt / Equity Ratio	-0.65	-0.07	-0.09	-0.15
Debt / EBITDA Ratio	-	-0.48	-0.28	-0.36
Debt / FCF Ratio	-	-0.51	-0.24	-0.34
Quick Ratio	0.41	0.46	5.86	10.45
Current Ratio	0.47	0.56	6.08	10.62
Return on Equity (ROE)	-	21.10%	78.70%	-
Return on Assets (ROA)	-	-95.30%	-8.60%	-
Return on Capital (ROIC)	-	19.62%	37.58%	58.59%
Earnings Yield	-10.61%	-5.01%	-4.67%
FCF Yield	-8.43%	-5.26%	-4.70%
Buyback Yield / Dilution	-31.66%	-0.93%	0.08%	-
Total Shareholder Return	-31.66%	-0.93%	0.08%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).